Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Combination of Lactobacillus Acidophilus DSMZ 26280 and Limosilolactobacillus Reuteri DSMZ 25441 Has an Impact on Clinical Course and Gut Microbiota of Children With Acute Infec-tious Diarrhea

NCT07342088 is registered in ClinicalTrials.gov with Eskisehir Osmangazi University as lead sponsor.

NCT NCT07342088
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07342088 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Combination of Lactobacillus Acidophilus DSMZ 26280 and Limosilolactobacillus Reuteri DSMZ 25441 Has an Impact on Clinical Course and Gut Microbiota of Children With Acute Infec-tious Diarrhea
Lead sponsor
Eskisehir Osmangazi University
Phase
Not applicable
Overall status
Completed
Start date
May 1, 2024
Completion date
April 30, 2025
Enrollment
145 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute gastroenteritis, infectious diarrhea